Java version shifts: Adoption of Java 21 jumped to 43%, up from 30% in 2024. Java 17 and Java 8 both saw declines, while Java 11 experienced a rebound and now stands at 37%. The data suggests that ...

At Indian Mounds Elementary in Bloomington, K-5 students are encouraged to incorporate computer science into every subject — boosting their tech skills and creativity along the way.

Chained To The Rhythm: The Month In Pop September 11, 2025 9:41 AM By Katherine St. Asaph A new month is upon us, and in pop in 2025 that means one thing: New sensitive dude just dropped. His name, ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

The Trump family-tied decentralized finance project World Liberty Financial has issued a governance proposal to implement a token buyback and burn program using protocol-owned liquidity fees. World ...

17-old-old Chicago rapper BabyChiefDoIt claims that his recent comments about using ChatGPT for lyrics was taken out of context. On Aug. 11, the "Went West" artist visited Power 105.1, where, around ...

A New York-based start-up company wants to use batteries to reduce stress on the energy grid and put money back in the pockets of state residents. The pilot program, courtesy of Standard Potential in ...

More than a dozen House Democrats pressed Centers for Medicare & Medicaid Services (CMS) Administrator Mehmet Oz in a letter last week over CMS's announced plans to expand prior authorization ...

I used to believe I taught the one genre that artificial intelligence couldn’t touch. For 15 years, I’ve guided college students through the deeply human work of personal narrative, helping them ...

ECLIPSE registrational program now fully underway, following enrollment of the first patient in ECLIPSE 3 ECLIPSE 3 is designed to compare the combination of tobevibart and elebsiran to bulevirtide in ...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in the ECLIPSE 2 Phase 3 clinical trial, which is designed to compare the ...